Výsledky vyhledávání - "Nina, Baltes"

Data from Differential Antitumor Activity of Aflibercept and Bevacizumab in Patient-Derived Xenograft Models of Colorectal Cancer

Autor: Donald A. Bergstrom, Nina Baltes, Catherine Geslin, Loïc Vincent, Christophe Henry, Parminder K. Mankoo, Jack Pollard, Rebecca G. Bagley, Marielle Chiron

The recombinant fusion protein aflibercept (ziv-aflibercept in the United States) binds VEGF-A, VEGF-B, and placental growth factor (PlGF). The monoclonal antibody bevacizumab binds VEGF-A. Recent studies hypothesized that dual targeting of VEGF/PlGF

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0436a22971eef8a9ed9207a5d2029609
https://doi.org/10.1158/1535-7163.c.6536281

Zobrazit plný text záznamu

Supplementary Figure 2 from Differential Antitumor Activity of Aflibercept and Bevacizumab in Patient-Derived Xenograft Models of Colorectal Cancer

Autor: Donald A. Bergstrom, Nina Baltes, Catherine Geslin, Loïc Vincent, Christophe Henry, Parminder K. Mankoo, Jack Pollard, Rebecca G. Bagley, Marielle Chiron

PDF - 6591K, Tumor growth curves utilizing median ATVs of the 48 CRC PDXs: Tumor growth curves for all 48 patient-derived CRC tumors in mice engrafted SC, and which were treated with aflibercept SC injection (2x/week, 25 mg/kg), vehicle (SC injection

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55f2be435d33148c1f72a5ed1e7ced93
https://doi.org/10.1158/1535-7163.22499845.v1

Zobrazit plný text záznamu

Supplementary Figure 4 from Differential Antitumor Activity of Aflibercept and Bevacizumab in Patient-Derived Xenograft Models of Colorectal Cancer

Autor: Donald A. Bergstrom, Nina Baltes, Catherine Geslin, Loïc Vincent, Christophe Henry, Parminder K. Mankoo, Jack Pollard, Rebecca G. Bagley, Marielle Chiron

PDF - 44K, Distribution of the tumor origin across PDX models: Of the 48 PDX tumors, 8 were derived from primary patient tumors, 36 from metastatic sites, 1 from a site of recurring disease, and 1 of unknown anatomical origin. All of the primary tumo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dacd48091d28a8602c397c34c181261
https://doi.org/10.1158/1535-7163.22499839.v1

Zobrazit plný text záznamu

Supplementary Figure 3 from Differential Antitumor Activity of Aflibercept and Bevacizumab in Patient-Derived Xenograft Models of Colorectal Cancer

Autor: Donald A. Bergstrom, Nina Baltes, Catherine Geslin, Loïc Vincent, Christophe Henry, Parminder K. Mankoo, Jack Pollard, Rebecca G. Bagley, Marielle Chiron

PDF - 6683K, Tumor growth curves utilizing mean ATVs of the 48 CRC PDXs: Tumor growth curves for all 48 patient-derived CRC tumors in mice engrafted SC, and which were treated with aflibercept SC injection (2x/week, 25 mg/kg), vehicle (SC injection,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13e536ed03cdbb6f747a0a9da08181b9
https://doi.org/10.1158/1535-7163.22499842

Zobrazit plný text záznamu

An isogenic Actinobacillus pleuropneumoniae AasP mutant exhibits altered biofilm formation but retains virulence

Autor: Halina E. Tegetmeyer, Nina Baltes, Kerstin Fricke

Publikováno v: Veterinary Microbiology. 137:392-396

AasP, an autotransporter serine protease of Actinobacillus pleuropneumoniae, has been shown to be expressed in necrotic porcine lung tissue. Based on the hypothesis that AasP might play an important role in A. pleuropneumoniae adhesion and virulence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b613ad13d8c7a1e4d3955e970cd60a
https://doi.org/10.1016/j.vetmic.2009.01.026

Zobrazit plný text záznamu

Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection

Autor: Gerald-F. Gerlach, Alexander Maas, Jochen Meens, Nina Baltes, Isabel Hennig-Pauka

Publikováno v: Vaccine. 24:7226-7237

Actinobacillus pleuropneumoniae is the causative agent of porcine pleuropneumonia which leads to high economic losses in the swine industry worldwide. Vaccination against this pathogen is hampered by the occurrence of 15 serotypes, and commonly used

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c084abb26d2401676f2bdd5155cb7c5
https://doi.org/10.1016/j.vaccine.2006.06.047

Zobrazit plný text záznamu

Deletion of the Anaerobic Regulator HlyX Causes Reduced Colonization and Persistence of Actinobacillus pleuropneumoniae in the Porcine Respiratory Tract

Autor: Mohamed N'diaye, Nina Baltes, Gerald-F. Gerlach, Ilse D. Jacobsen, Alexander Maas, Falk F. R. Buettner

Publikováno v: Infection and Immunity. 73:4614-4619

Actinobacillus pleuropneumoniae , the etiological agent of porcine pleuropneumonia, is able to persist on respiratory epithelia, in tonsils, and in the anaerobic environment of encapsulated lung sequesters. We have demonstrated previously that putati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ddebb8046c316e9ea4a9961c1b4076a
https://doi.org/10.1128/iai.73.8.4614-4619.2005

Zobrazit plný text záznamu

Identification of Genes Transcribed by Actinobacillus pleuropneumoniae in Necrotic Porcine Lung Tissue by Using Selective Capture of Transcribed Sequences

Autor: Nina Baltes, Gerald-F. Gerlach

Publikováno v: Infection and Immunity. 72:6711-6716

Genes expressed by Actinobacillus pleuropneumoniae in necrotic porcine lung tissue were identified by selective capture of transcribed sequences analysis. In total, 46 genes were identified, 20 of which have been previously reported to be associated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d899adc5cc219d48f8d11aa89174ae5
https://doi.org/10.1128/iai.72.11.6711-6716.2004

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání